BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months
Artesunate: trial readouts and FDA decisions
3 upcoming industry Phase 2/3 readout(s) in the next 90 days, 0 upcoming FDA event(s), 0 readout(s) in the last 180 days and 0 FDA event(s) in the last 12 months. Sponsors: Frantz Viral Therapeutics, LLC. Drug names come from ClinicalTrials.gov intervention names and FDA records, lightly normalised; one drug can appear under several names (code, generic, brand).
Upcoming trial readouts
| Readout | Phase | Sponsor | Trial | Conditions | Status | Enrollment |
|---|---|---|---|---|---|---|
| 2026-12 est. | P2 | Frantz Viral Therapeutics, LLC | NCT06075264 Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3) | Vulvar Diseases; HPV Infection; Vulvar HSIL; Pre-Cancerous Dysplasia; HPV Disease; VIN, Usual Type; | recruiting | 27 |
| 2026-12-28 est. | P2 | Frantz Viral Therapeutics, LLC | NCT05555862 Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL | Anal High Grade Squamous Intraepithelial Lesion; Anal Precancerous Condition; AIN 2/3; HPV Infection | active not recruiting | 17 |
| 2026-12-31 est. | P2 | Frantz Viral Therapeutics, LLC | NCT06206564 Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants | Anal High-grade Squamous Intraepithelial Lesion; Anal HSIL; Anal HPV Infection; AIN | recruiting | 48 |
Readouts, last 180 days
| Readout | Phase | Sponsor | Trial | Conditions | Status | Enrollment |
|---|---|---|---|---|---|---|
| None in the last 180 days. | ||||||
Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line
results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are
company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA
(openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score.
Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP
readout_calendar / fda_decisions. Not investment advice.